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The fungal pathogen Candida albicans causes lethal systemic infections in humans. To better define how pathogens resist oxidative attack by the immune system, we examined a
family of four Flavodoxin-Like Proteins (FLPs) in C. albicans. In agreement with previous
studies showing that FLPs in bacteria and plants act as NAD(P)H quinone oxidoreductases,
a C. albicans quadruple mutant lacking all four FLPs (pst1Δ, pst2Δ, pst3Δ, ycp4Δ) was
more sensitive to benzoquinone. Interestingly, the quadruple mutant was also more sensitive to a variety of oxidants. Quinone reductase activity confers important antioxidant effects
because resistance to oxidation was restored in the quadruple mutant by expressing either
Escherichia coli wrbA or mammalian NQO1, two distinct types of quinone reductases. FLPs
were detected at the plasma membrane in C. albicans, and the quadruple mutant was more
sensitive to linolenic acid, a polyunsaturated fatty acid that can auto-oxidize and promote
lipid peroxidation. These observations suggested that FLPs reduce ubiquinone (coenzyme
Q), enabling it to serve as an antioxidant in the membrane. In support of this, a C. albicans
coq3Δ mutant that fails to synthesize ubiquinone was also highly sensitive to oxidative
stress. FLPs are critical for survival in the host, as the quadruple mutant was avirulent in a
mouse model of systemic candidiasis under conditions where infection with wild type C.
albicans was lethal. The quadruple mutant cells initially grew well in kidneys, the major site
of C. albicans growth in mice, but then declined after the influx of neutrophils and by day 4
post-infection 33% of the mice cleared the infection. Thus, FLPs and ubiquinone are important new antioxidant mechanisms that are critical for fungal virulence. The potential of FLPs
as novel targets for antifungal therapy is further underscored by their absence in mammalian cells.

Author Summary
Oxidative damage is a fundamental problem for cells and a particular challenge for microbial pathogens, which require special mechanisms to resist the oxidative attack by the host
immune system. We identified four proteins in the human fungal pathogen Candida
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albicans that belong to a large family of enzymes in bacteria and plants that reduce quinone molecules to detoxify them. Interestingly, mutational studies in C. albicans showed
that these enzymes also confer resistance to a wide range of oxidants, suggesting they may
have broader impact by reducing the major quinone present in cells (ubiquinone or coenzyme Q). In support of this, we found that mutating the COQ3 gene to block ubiquinone
synthesis rendered cells highly sensitive to oxidative stress, revealing that it plays a very
important antioxidant function in addition to its well known role in energy metabolism.
These quinone reductases play a critical role in vivo, as they were required for virulence in
mouse infections studies. Since mammalian cells lack this type of quinone reductase, this
difference could be exploited to develop much needed novel therapeutic approaches for
fungal and bacterial pathogens.

Introduction
Oxidative stress poses a great threat to cells. Unchecked oxidative damage to DNA, proteins,
and lipids causes disruption of physiological processes, harmful mutations, and cell death [1].
To prevent these destructive effects, cells utilize a variety of mechanisms to protect against oxidation. These antioxidant mechanisms are especially important for pathogens to resist the oxidative attack by the immune system [2]. As a result, the human fungal pathogen Candida
albicans relies on several different mechanisms, such as extracellular, cytoplasmic, and mitochondrial forms of superoxide dismutases to break down superoxide radicals [3–5]. Other
intracellular mechanisms include catalase to detoxify H2O2 and glutathione to promote a
reducing environment [6].
Cellular membranes require special protection from oxidation. The plasma membrane is
particularly vulnerable because it directly faces oxidative attack by macrophages and neutrophils. Protecting the plasma membrane is critical for survival. In addition to forming a protective barrier around the cell, it functions in a wide range of essential processes including
nutrient uptake, ion homeostasis, pH regulation, cell wall synthesis, and morphogenesis. This
membrane is also vulnerable because it contains polyunsaturated fatty acids (PUFAs). Approximately 30% of the C. albicans fatty acids are polyunsaturated linoleic (18:2) or linolenic (18:3)
acids [7, 8]. PUFAs are very sensitive to peroxidation due to the ease with which the hydrogens
can be abstracted from the methylene bridges (-CH2-) that lie in between the double bonds [9,
10]. This leaves an unpaired electron on the carbon that can react with O2 to form a peroxyl
radical, which can in turn abstract the hydrogen from another PUFA to continue the cycle.
Thus, lipid peroxidation starts a chain reaction that propagates to other lipids. The resulting
oxidative damage can also spread to other cellular constituents, including proteins and DNA.
Several lines of evidence suggested that a family of four uncharacterized Flavodoxin-Like
Proteins (FLPs) present in C. albicans could play a novel antioxidant role at the plasma membrane. The FLPs, which are encoded by PST1, PST2, PST3, and YCP4, are induced by oxidative
stress [11]. The FLP genes contain consensus sites in their promoter regions for the binding of
Cap1, a transcription factor that is induced by oxidative stress, and for a subset of these genes
Cap1 has been shown to bind to the promoter and regulate expression [12, 13]. The S. cerevisiae FLPs (Pst2, Rfs1, Ycp4) have been suggested to promote resistance to oxidative stress [14–
16], although their physiological role is not known [17]. It is also interesting that the C. albicans
FLPs are likely to act at the plasma membrane, since their orthologs in S. cerevisiae are associated with the plasma membrane [18].
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Fig 1. C. albicans FLP genes are needed for resistance to oxidative stress. (A) Structures of oxidized benzoquinone, reduced benzoquinol, and the
semiquinone intermediate that is a reactive oxygen species. Two-electron reduction of quinones avoids creation of the semiquinone intermediate. (B) Serial
10-fold dilutions of cells were spotted onto synthetic medium agar plates containing the indicated chemical and then incubated at 37°C for 48 h. Quinones
tested included BZQ (p-benzoquinone) and MND (menadione). Oxidants included H2O2, as well as more hydrophobic peroxides that target the membrane:
TBHP (tert-butyl hydroperoxide) and CHP (cumene hydroperoxide). In addition, monounsaturated OA (oleic acid) was used as a control for the
polyunsaturated LNA (linolenic acid), which is known to induce lipid peroxidation. Strains used were the wild type strain LLF100, Δ/Δ/Δ/Δ strain LLF060
(pst1Δ pst2Δ pst3Δ ycp4Δ), and the complemented strain LLF079 in which one copy of each FLP gene was introduced into the Δ/Δ/Δ/Δ strain (pst1Δ pst2Δ
pst3Δ ycp4Δ PST1 PST2 PST3 YCP4).
doi:10.1371/journal.ppat.1005147.g001

The FLPs are highly conserved in bacteria, plants, and fungi, but surprisingly not in mammalian cells [19]. Biochemically, the most well studied FLP is the E. coli WrbA protein. It uses
flavin mononucleotide (FMN) as a cofactor and acts as a NAD(P)H quinone oxidoreductase
[20–22]. FLPs from fungi, plants and other bacteria have also been shown to act as NAD(P)H
quinone oxidoreductases, indicating that this is a conserved property of this family [15, 23–27].
A special feature of FLPs is that they carry out a two-electron reduction of a quinone to quinol
(see structures in Fig 1A). This converts both carbonyl groups on the benzoquinone ring to
hydroxyl groups. In contrast, other pathways that promote a one-electron reduction of quinone
form a semiquinone intermediate that is a hazardous reactive oxygen species [9, 10]. Although
the physiological role of WrbA is not known, there is suggestive evidence that it promotes resistance to oxidative stress [19, 21, 27].
Quinone reductases could promote resistance to oxidative stress in several ways. One is that
they can reduce and detoxify small molecule quinones that are produced by some organisms
for defense or created as benzene metabolites [28, 29]. In addition, they could act on endogenously produced quinones, such as ubiquinone (coenzyme Q), an isoprenylated benzoquinone.
Ubiquinone is well known for its role in the mitochondrial electron transport chain, but it is
also present in other cellular membranes, where it can undergo redox cycling to act as an antioxidant [30–34]. Mammalian cells use the enzyme Nqo1 (NAD(P)H quinone oxidoreductase),
formerly known as DT-diaphorase, to safely carry out a two-electron reduction of ubiquinone
and avoid semiquinone formation [35, 36]. Nqo1 is analogous to FLPs in that it uses NAD(P)
H for reducing potential, but it differs in overall amino acid sequence and the active site is distinct from the FLPs, in part due to the fact that the active site of Nqo1 binds FAD as a cofactor
rather than FMN [19]. However, it is not known how fungal cells, including C. albicans, carry
out this function since they lack an obvious ortholog of NQO1. Therefore, in this study we
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examined a quadruple mutant lacking all four FLP genes (PST1, PST2, PST3 and YCP4). The
results demonstrate that these proteins represent a new mechanism for protecting C. albicans
against oxidative stress that is required for virulence in a mouse model of systemic candidiasis.

Results
C. albicans mutant lacking all four FLP genes is more sensitive to
oxidation
Four FLPs were identified in C. albicans based on their high sequence identity (45–50%) and
similarity (~65%) to the well-studied E. coli WrbA (S1 Fig). This type of enzyme is advantageous because it uses NAD(P)H to carry out a two-electron reduction of toxic quinones that
avoids creation of the semiquinone radical (Fig 1A) [21]. The conserved residues are concentrated in the active site near the location of the FMN co-factor. The four C. albicans FLPs share
a similar structure, although Ycp4 contains C-terminal extension of about 90 amino acids that
ends in a CAAX box, indicating it is likely to be lipid modified (S1 Fig). To examine their role
in the diploid C. albicans, a quadruple mutant strain was constructed that lacks both copies of
all four FLP genes. Fortuitously, PST3 and YCP4 are adjacent in the genome and were deleted
simultaneously using the HIS1 and LEU2 selectable markers. Subsequent deletion of the PST1
and PST2 genes was carried out by successive use of the SAT Flipper that employs a recyclable
SAT1 selectable marker [37]. For brevity, this pst1Δ pst2Δ pst3Δ ycp4Δ strain will be referred to
as the Δ/Δ/Δ/Δ mutant. The sensitivity of this strain to quinones was tested by spotting dilutions of cells onto agar medium containing p-benzoquinone (BZQ) or menadione (MND), a
heterocyclic napthoquinone (Fig 1B). The growth of the Δ/Δ/Δ/Δ strain was clearly inhibited
by these small molecule quinones, indicating it is more sensitive to quinones than either the
wild type control or a complemented strain in which one copy of each of the FLP genes was
reintroduced.
FLPs in bacteria and plants have also been suggested to have a role in fighting oxidative
stress, but their physiological role is not known [19, 21, 25, 27]. Therefore, given the importance of antioxidant enzymes for microbial pathogens, we spotted the cells on medium containing H2O2 and found that the Δ/Δ/Δ/Δ mutant was more sensitive to this oxidant (Fig 1B).
Since the FLPs are associated with the plasma membrane in S. cerevisiae [18], we further tested
two other peroxides that are more hydrophobic. Interestingly, the Δ/Δ/Δ/Δ mutant was also
very sensitive to tert-butyl hydroperoxide (TBHP) and cumene hydroperoxide (CHP), which
are more hydrophobic than H2O2 and more likely to preferentially oxidize membranes.
The Δ/Δ/Δ/Δ mutant was next assayed for sensitivity to polyunsaturated fatty acids
(PUFAs), which can auto-oxidize and initiate a chain reaction of lipid peroxidation [10, 33].
PUFAs are more readily oxidized because the presence of double bonds flanking a methylene
group (-CH2-) weakens the methylene C-H bond, making it much easier to abstract a hydrogen
[9]. This leaves a carbon with an unpaired electron that readily reacts with oxygen to form a
peroxyl radical (LOO•). For example, linolenic acid, which has three unsaturated double
bonds, is much more likely to auto-oxidize to form a peroxyl radical than is monounsaturated
oleic acid. The peroxyl radical can then abstract a hydrogen from another PUFA to form a
lipid peroxide (LOOH) and a new lipid radical that can further extend a chain reaction of lipid
peroxidation [9, 10]. Linolenic acid was also used for this analysis because previous studies
showed that it efficiently induced lipid peroxidation and cell death in S. cerevisiae [33]. Interestingly, growth of the Δ/Δ/Δ/Δ mutant was strongly inhibited by the polyunsaturated linolenic
acid (LNA; Fig 1B). In contrast, the Δ/Δ/Δ/Δ mutant grew as well as the control cells in the
presence of the monounsaturated oleic acid (OA). Taken together, these results indicate that
the FLPs are needed for C. albicans to combat a variety of oxidative stresses.
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Fig 2. The Δ/Δ/Δ/Δ mutant strain is more sensitive to linolenic acid-induced cell death and lipid peroxidation. (A) C. albicans strains were incubated
with 0.5 mM linolenic acid (LNA) at 37°C for the indicated time (hours), and then dilutions of cells were plated to determine the viable colony forming units
(CFU). (B) Cells were incubated with 0.5 LNA for the different times and then thiobarbituric acid reactive substance (TBARS) assays were carried out to
detect malondialdehyde (MDA), a byproduct of lipid peroxidation. (C) Cells were exposed to different concentrations of LNA for 6 h, and then CFUs were
determined. (D) TBARS assays to detect lipid peroxidation in cells treated with different concentrations of LNA for 6 h. (E) CFU analysis and (F) TBARS
assays of the indicated FLP mutant strains. Note that in contrast to the Δ/Δ/Δ/Δ quadruple mutant strain LLF060, the single, double and triple FLP deletion
mutant strains did not display increased sensitivity to LNA. Error bars indicate SE. * = p<0.05, ** = p<0.01, *** = p< 0.001 by ANOVA. Strains used included
the wild type strain LLF100, Δ/Δ/Δ/Δ strain LLF060, and the complemented strain LLF079 in which one copy of each FLP gene was introduced into the Δ/Δ/Δ/
Δ strain.
doi:10.1371/journal.ppat.1005147.g002

FLPs are needed to prevent lipid peroxidation
The effects of linolenic acid on C. albicans were analyzed further in quantitative assays. A time
course of cell death was assayed by incubating cells for different times in the presence of 0.5
mM linolenic acid followed by plating dilutions on agar medium to determine the viable colony
forming units (CFUs). The results confirmed the spotting assays. The Δ/Δ/Δ/Δ mutant showed
a significant trend toward decreased viability by 6–8 h that was not observed for the wild-type
control or complemented strains (Fig 2A). Analysis of the dose-response to incubation with
linolenic acid for 6 h revealed a loss of viability starting at 0.25 mM that became more significant at 0.5 and 1.0 mM (Fig 2C). In contrast, the cells remained viable after incubation in the
monounsaturated oleic acid (S2 Fig).
To determine whether linolenic acid caused an increase in lipid peroxidation, cells were
assayed for thiobarbituric acid reactive substances (TBARS) [33, 38]. This assay detects malondialdehyde (MDA), a common byproduct of lipid peroxidation. As expected, both the Δ/Δ/Δ/Δ
mutant and the control cells showed elevated TBARS after incubation for different times with
linolenic acid (Fig 2B). However, the Δ/Δ/Δ/Δ mutant showed a significantly higher level of
TBARS than the control cells at 4 and 6 h. By 8 h, the results of the TBARS assays were quite
variable. This may have been due to difficulties in dealing with the high fraction of dead cells
during the analysis. Dose-response assays showed that the TBARS in the Δ/Δ/Δ/Δ mutant
started trending upward at 0.25 mM and was significantly higher than control cells at 0.5 mM
and 1.0 mM linolenic acid (Fig 2D). These results demonstrate that linolenic acid stimulated
higher levels of lipid peroxidation in the Δ/Δ/Δ/Δ mutant.
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For comparison, mutants lacking a single FLP gene (pst1Δ, pst2Δ, pst3Δ or ycp4Δ), two
genes (pst3Δ ycp4Δ), or three genes (pst2Δ, pst3Δ ycp4Δ) were also tested for their sensitivity to
0.5 mM linolenic acid (Fig 2E and 2F). However, no significant changes in either CFU or lipid
peroxidation level were detected compared to the wild type control. As will be described further
below, this is consistent with redundancy of the different FLP genes in C. albicans.
To gain additional evidence that the effects of linolenic acid were due to oxidation, cells
were incubated with α-tocopherol (vitamin E), a hydrophobic reducing agent that localizes to
membranes and has been shown to prevent lipid peroxidation in other organisms [9, 33].
Treatment of cells with α-tocopherol alone had no detectable effects on CFUs or lipid peroxidation. In contrast, the addition of α-tocopherol significantly decreased the killing activity of
linolenic acid in both WT and the Δ/Δ/Δ/Δ mutant (Fig 3A). Similarly, α-tocopherol reduced

Fig 3. Antioxidant Vitamin E blocks the effects of linolenic acid. Cells were suspended in phosphate
buffer (0.1M Na2HPO4, 0.2% dextrose) containing 0.5 mM oleic acid (OA), 0.5 mM linolenic acid (LNA), 0.5
mM vitamin E (α-tocopherol; Vit E), or 0.5mM LNA + 0.5 mM Vit E. After incubation at 37°C for 6 h, (A) cells
were plated to determine CFU or (B) they were assayed for TBARS. The wild type strain was LLF100 and the
Δ/Δ/Δ/Δ strain was LLF060. Error bars indicate SE. * = p<0.05, ** = p<0.01, *** = p< 0.001 by ANOVA.
doi:10.1371/journal.ppat.1005147.g003
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the levels of lipid peroxidation to below the limit of detection, as determined by the TBARS
assay (Fig 3B).

Heterologous expression of known NAD(P)H quinone oxidoreductases
rescues the phenotypes of the Δ/Δ/Δ/Δ
To confirm whether quinone reductase activity is important to promote resistance to oxidative
stress in C. albicans, the Δ/Δ/Δ/Δ mutant was engineered to express two distinct types of NAD
(P)H quinone oxidoreductases: rat NQO1 and E. coli wrbA. NQO1 and wrbA were selected
because their proteins have been well-studied biochemically [21, 39, 40]. These genes were
expressed under the control of the strong ADH1 promoter. As a control, cells were also engineered to express GFP in a similar manner. Incubation of the cells in the presence of 0.5 mM
linolenic acid for 6 h showed that expression of either wrbA or NQO1 rescued the viability of
the Δ/Δ/Δ/Δ mutant (Fig 4A). In contrast, the Δ/Δ/Δ/Δ mutant or the Δ/Δ/Δ/Δ mutant that
expressed only GFP showed a significant drop in CFUs. Similarly, expression of wrbA or
NQO1, but not GFP, diminished lipid peroxidation in cells that were exposed to linolenic acid
(Fig 4B). Growth assays on agar plates also showed that wrbA and NQO1 could complement
the increased sensitivity of the Δ/Δ/Δ/Δ mutant to H2O2, tert-butyl hydroperoxide, cumene
hydroperoxide and menadione (Fig 4C). The ability of two distinct quinone reductases to complement the Δ/Δ/Δ/Δ mutant phenotype demonstrates that this activity plays a key antioxidant
role in C. albicans.

Fig 4. Heterologous expression of E. coli wrbA or rat NQO1 rescues the sensitivity of Δ/Δ/Δ/Δ mutant to oxidants. The distinct NAD(P)H quinone
oxidoreductase genes wrbA and NQO1 were expressed in the Δ/Δ/Δ/Δ strain under control of the ADH1 promoter. A control strain was also constructed in a
similar manner that expressed GFP. The cells were then incubated with 0.5 mM linolenic acid (LNA) for 6 h at 37˚C and then (A) assayed for viable CFUs or
(B) assayed for TBARS as an indicator of lipid peroxidation. Some cells in panel A were also incubated with oleic acid (OA) as a control. (C) Dilutions of cells
were spotted onto different agar plates containing synthetic medium and the indicated oxidant, and then incubated at 37°C for 2 d. The plates contained
H2O2, tert-butyl hydroperoxide (TBHP), cumene hydroperoxide (CHP), menadione (MND), monounsaturated oleic acid (OA), and polyunsaturated linolenic
acid (LNA). Strains used included the wild type control strain LLF100, Δ/Δ/Δ/Δ strain LLF060, the complemented strain LLF079, and the Δ/Δ/Δ/Δ strain in
which E. coli wrbA (LLF074), rat NQO1 (LLF076) or GFP (LLF080) was expressed under control of the constitutive ADH1 promoter. Error bars indicate SE. *,
p <0.05 by ANOVA.
doi:10.1371/journal.ppat.1005147.g004
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Functional differences between NAD(P)H quinone oxidoreductase
homologues
The properties of the different quinone reductase homologues were examined by expressing
individual genes in the Δ/Δ/Δ/Δ mutant. The C. albicans genes were reintroduced under control
of their native promoters, whereas wrbA and NQO1 were controlled by the ADH1 promoter.
Growth assays were performed to test the ability of cells carrying only one quinone reductase
gene to resist different quinones and oxidants. All of the different quinone reductases were able
to promote resistance to H2O2, tert-butyl hydroperoxide, and linolenic acid (Fig 5A). However,
some of the strains had differential ability to resist cumene hydroperoxide and the small molecule quinones: p-benzoquinone and menadione (Fig 5A and summarized in Fig 5B).
The strain expressing only PST3 was very interesting in that it showed the strongest resistance to p-benzoquinone and menadione (Fig 5A). Although several strains displayed obvious
resistance to 75 μM p-benzoquinone, only the PST3-expressing strain was resistant to 100 μM
p-benzoquinone. It grew remarkably better than the other strains, and nearly as well as the
complemented strain that carries one copy of each FLP gene. Similarly, it also grew better than
the other strains on medium containing menadione. In contrast, the PST3-expressing strain
did not show significant resistance to cumene hydroperoxide and was more weakly resistant to
linolenic acid, which are considered to be good inducers of lipid peroxidation. This strain was,
however, more resistant than the Δ/Δ/Δ/Δ mutant to H2O2 and tert-butyl hydroperoxide, indicating that it can provide protection against some oxidants. Thus, it appears that Pst3 can preferentially act on small molecule quinones. In agreement with this, a pst3Δ strain was sensitive
to the inhibitory effects of p-benzoquinone and menadione, whereas the pst1Δ, pst2Δ and
ycp4Δ mutants were not (Fig 5C). The increased sensitivity of the pst3Δ mutant to p-benzoquinone and menadione were the only phenotypes we detected for the single mutants as we did
not detect increased sensitivity to oxidizing conditions (Fig 2).
Some of the other strains expressing a single quinone reductase showed the opposite phenotype of being more resistant to oxidants than to the small molecule quinones. For example, the
strains expressing PST2, YCP4, wrbA, or NQO1 all showed improved resistance to cumene
hydroperoxide and linolenic acid compared to the Δ/Δ/Δ/Δ mutant, but were not significantly
more resistant or were more weakly resistant to the small molecule quinones under the conditions tested (Fig 5A). The different phenotypes indicate that there are functional differences
between the various quinone reductases.

Ubiquinone promotes resistance to oxidative stress, but not small
molecule quinones
The major quinone found in cells, ubiquinone (coenzyme Q), is known to have two key functions. It plays a central role in the mitochondrial electron transport chain, and it is also present
in other cellular membranes where it can function as an antioxidant [30–34]. To investigate
the relationship between ubiquinone and oxidative stress, both copies of COQ3 were deleted
from C. albicans to prevent ubiquinone synthesis. As expected, a C. albicans coq3Δ mutant was
not able to grow on glycerol, a carbon source that requires respiration to be utilized (Fig 6A).
In contrast, the Δ/Δ/Δ/Δ mutant readily grew on glycerol (Fig 6A). Interestingly, the coq3Δ
mutant was very sensitive to H2O2, even more so than the Δ/Δ/Δ/Δ mutant (Fig 6A). Spot
assays also showed that the coq3Δ mutant was more sensitive to linolenic acid than the Δ/Δ/Δ/
Δ mutant. For comparison, two previously constructed mitochondrial mutants were examined
that lack components of Complex I of the electron transport chain [41]. Both orf19.2570Δ and
orf19.6607Δ failed to grow on glycerol medium, as expected (Fig 6A). However, they were not
more sensitive to linolenic acid and showed perhaps only a minor increase in sensitivity to
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Fig 5. Differential sensitivity to oxidants for C. albicans strains expressing a single FLP gene or the analogous NQO1 gene. Strains expressing
individual C. albicans FLP genes under control of their native promoter, or the E. coli wrbA or rat NQO1 gene under control of the ADH1 promoter were
created by introducing the corresponding genes into the Δ/Δ/Δ/Δ mutant strain LLF054. (A) Serial 10-fold dilutions of cells were spotted onto agar plates
containing synthetic medium and the indicated chemical. Plates were incubated at 37°C for 48 h and then photographed. (B) Summary of mutant phenotypes
shown in panel A. A brighter yellow color indicates better cell growth of under the specified condition. Black indicates no growth detected. The values were
determined from the relative extent of growth detected in two to three independent spot assays as shown in panel A. (C) Deletion mutant strains lacking a
single FLP gene were spotted onto medium containing the indicated quinones. Note that the pst3Δ strain was more sensitive. Strains used included the wild
type control strain LLF100, Δ/Δ/Δ/Δ strain LLF060, and the complemented strain LLF079. Also, the Δ/Δ/Δ/Δ strain engineered to express E. coli wrbA (strain
LLF074), rat NQO1 (strain LLF076), GFP (strain LLF080), PST1 (LLF064), PST2 (LLF081), PST3 (LLF066) or YCP4 (LLF082). Single mutant deletion strains
used in panel C were pst1Δ (LLF052), pst2Δ (LLF059), pst3Δ (LLF036), and ycp4Δ (LLF037).
doi:10.1371/journal.ppat.1005147.g005

PLOS Pathogens | DOI:10.1371/journal.ppat.1005147 September 1, 2015

9 / 24

New Antioxidant Mechanism for Fungal Pathogens

Fig 6. Comparison of the Δ/Δ/Δ/Δ mutant with a coq3Δ mutant that fails to produce ubiquinone. The Δ/Δ/Δ/Δ mutant was compared with a coq3Δ
mutant (LLF088) and two representative mitochondrial mutants, orf19.2570Δ, and orf19.6670Δ. (A) Serial 10-fold dilutions of cells were spotted onto agar
plates containing synthetic medium and the indicated carbon source, or with dextrose plus H2O2. Plates were incubated at 37°C for 48 h and then
photographed. (B) Cells were treated for 6 hours in the presence of 0.5mM LNA, and then assayed for viable CFUs, or (C) assayed for TBARS as an indicator
of lipid peroxidation. Error bars indicate SE.
doi:10.1371/journal.ppat.1005147.g006

H2O2. This indicates that a mitochondrial defect does not account for the increased sensitivity
to oxidation of the coq3Δ mutant, consistent with ubiquinone also playing a major role as an
antioxidant.
Analysis of cell viability after incubation with 0.5 mM linolenic acid for 6 h revealed a larger
drop in CFUs for the coq3Δ mutant than for the Δ/Δ/Δ/Δ mutant (Fig 6B). The coq3Δ mutant
also displayed significantly higher levels of TBARS under these conditions (Fig 6C). Similar
results have been observed in S. cerevisiae, as a coq3Δ mutant in this yeast is also sensitive to
oxidation and lipid peroxidation [33]. These results demonstrate that ubiquinone plays an
important role as an antioxidant to prevent lipid peroxidation and oxidative stress in C.
albicans.
It is noteworthy that the coq3Δ mutant was not significantly more sensitive to p-benzoquinone and menadione, even though it was very sensitive to H2O2 and linolenic acid (Fig 6A).
This suggests that the FLPs in C. albicans can detoxify these small molecule quinones in the
absence of ubiquinone, thereby prevent them from causing oxidative damage.

FLPs localize to the plasma membrane in C. albicans
FLPs were fused to GFP to examine their subcellular localization. Pst1-GFP and Pst3-GFP
were detected at the plasma membrane by fluorescence microscopy (Fig 7A). To improve
detection for the other two FLPs, the strong ADH1 promoter was used to express GFP fusions
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Fig 7. Plasma membrane localization of the C. albicans FLP proteins. Fluorescence microscopy of C.
albicans cells producing (A) Pst1-GFP and Pst3-GFP fusion proteins in which GFP was added to the C
terminus. (B) Cells producing GFP-Pst2 and GFP-Ycp4 fusions in which GFP was added to the N terminus.
The GFP fusion genes in panel A were regulated by their endogenous promoters, whereas the fusion genes
in panel B were expressed using the ADH1 promoter.
doi:10.1371/journal.ppat.1005147.g007

to the PST2 and YCP4 genes. These GFP-Pst2 and GFP-Ycp4 fusion proteins gave a strong
plasma membrane signal (Fig 7B). The GFP-tagged FLPs all showed a slightly patchy distribution in the plasma membrane, suggesting that they localize in part to the eisosome subdomains,
as do their S. cerevisiae orthologs [18, 42]. Cytoplasmic GFP signal was also detected in cells.
However, this could be due to proteolytic cleavage of the FLP proteins resulting in the presence
of free cytoplasmic GFP, as Western blot analysis detected a strong signal at the expected size
of GFP (~30 kD) (S3 Fig).

The FLP genes promote C. albicans virulence in mice
The role of the FLPs in virulence was examined using a mouse model of hematogenously disseminated candidiasis [43]. After injection via the tail vein with 2.5 x 105 C. albicans cells,
BALB/c mice infected with the wild type control strain succumbed to infection with a median
time of 8 days (Fig 8A). Similar results were observed for the complemented version of the Δ/
Δ/Δ/Δ strain. In contrast, all mice infected with the Δ/Δ/Δ/Δ mutant survived to the end of the
experiment (Day 28). No CFUs were detected in the kidneys from these mice, indicating that
they had cleared the infection (Fig 8B).
To determine whether the Δ/Δ/Δ/Δ mutant failed to initiate an infection, or if it was cleared
more rapidly, kidneys were examined at early times post infection. The kidney is a sensitive
organ to test the ability of C. albicans to initiate an infection, since this fungus grows rapidly in
the kidneys during the first two days after infection [44, 45]. At day 2 post infection, the wild
type and Δ/Δ/Δ/Δ mutant were both present at similarly high levels of CFU/g kidney, indicating
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Fig 8. The Δ/Δ/Δ/Δ mutant is avirulent in a mouse model of systemic candidiasis. (A) 2.5 x 105 C
albicans cells were injected via the tail vein into 8-week old female Balb/c mice. Fourteen mice were injected
with the wild type control strain LLF100, and 8 mice each were injected with either the Δ/Δ/Δ/Δ strain LLF060
or the complemented strain LLF079. The mice were then monitored for survival over the next 28 d. (B) Mice
were infected as described above and then CFU per g kidney was determined at day 2, 4 or 28 post infection.
**, p < 0.01 by ANOVA. Six mice were infected with each strain for the day 2 analysis, 8 wild type control and
9 Δ/Δ/Δ/Δ mice were infected for the day 4 analysis, and 8 mice were infected with the Δ/Δ/Δ/Δ strain for the
day 28 analysis (which correspond the same mice shown in panel A). (C) Histological analysis of kidneys
harvested from mice 2 d after infection with 2.5 x 105 of wild type control of Δ/Δ/Δ/Δ mutant C. albicans cells.
Upper panels show representative areas of the kidney stained with Hematoxylin and Eosin (H&E) to detect
leukocytes (stained dark blue). Lower panels were stained with Gomori-methenamine silver (GMS) to detect
fungal cells (black).
doi:10.1371/journal.ppat.1005147.g008

they grew well initially (Fig 8B). Histological analysis showed that foci of C. albicans growth
in the kidney overlapped with clusters of leukocytes (Fig 8C). However, by the 4th day post
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infection, the median CFU/g kidney was 100-fold lower for mice infected with the Δ/Δ/Δ/Δ
mutant than the wild type. Furthermore, 33% of the mice (3/9) had no detectable CFU/g kidney at day 4, indicating that they had cleared the infection. Thus, the FLPs are required for the
persistence of C. albicans systemic infection.
Previous studies have shown that oxidation sensitive mutants, including those with defects
in catalase, thioredoxin, or superoxide dismutatase, show normal or only slightly increased sensitivity to killing by neutrophils [46]. Similar results were obtained when the Δ/Δ/Δ/Δ mutant
was examined for sensitivity to killing by macrophages derived from mouse bone marrow cells.
Although the Δ/Δ/Δ/Δ mutant showed a slight increase in killing by macrophages, the difference was not statistically significant (S4 Fig).
Analysis of the pst3Δ ycp4Δ double mutant and the pst2Δ pst3Δ ycp4Δ triple mutant showed
that they did not display a significant virulence defect in mice (S5 Fig). Mice infected with the
triple mutant appeared to show slightly increased survival (median 12.5 days) compared to the
wild type control strain (median 8 days), but this difference was not statistically significant
using a log rank test (Mantel-Haenszel). These results are consistent with the general redundancy of the FLP genes seen in the in vitro studies. In addition, since both the double and triple
mutant lack PST3, this indicates that the special role this FLP plays in detoxifying small quinones does not appear to be important in systemic candidiasis.

Discussion
Cells utilize a variety of pathways to protect against oxidation [1, 3, 5, 6]. Cytoplasmic mechanisms include superoxide dismutase, catalase, thioredoxin, and glutathione. In addition, pathogens have also evolved extracellular mechanisms. For example, C. albicans produces three
superoxide dismutases that are GPI-anchored and therefore on the cell surface or built into the
cell wall (Sod4-6) [5, 6]. One of these, Sod5, was recently shown to have unique properties in
that it uses copper as a co-factor, but not zinc [47]. This appears to be designed to take advantage of the fact that copper is pumped into phagosomes but zinc is restricted as part of the antimicrobial attack by leukocytes. However, it is not as well understood how cellular membranes
are protected from oxidation, particularly the fungal plasma membrane that is directly exposed
to the oxidative attack by neutrophils and macrophages [2].
To better understand how the plasma membrane is protected against oxidation we examined four FLPs in C. albicans that are associated with the plasma membrane (Fig 7). In agreement with their predicted role as NAD(P)H quinone oxidoreductases, a C. albicans Δ/Δ/Δ/Δ
quadruple mutant lacking all four FLP genes (PST1, PST2, PST3, and YCP4) displayed
increased sensitivity to p-benzoquinone and menadione, a napthoquinone (Fig 1). Interestingly, the mutant cells were also more sensitive to a wide range of oxidants, indicating that they
have a broader antioxidant function.
Consistent with the membrane localization of the FLPs, the Δ/Δ/Δ/Δ mutant was very sensitive to hydrophobic oxidants, including linolenic acid (Figs 1 and 5). The increased sensitivity
to linolenic acid was particularly significant, since previous studies demonstrated that this
PUFA auto-oxidizes and initiates a chain reaction of lipid peroxidation [33]. In agreement
with this, the Δ/Δ/Δ/Δ mutant showed elevated levels of TBARS (Fig 2), a hallmark of lipid peroxidation [9, 10]. Furthermore, the effects of linolenic acid could be reversed by the hydrophobic antioxidant α-tocopherol (Vitamin E) (Fig 3). Lipid peroxidation is likely to be a more
serious problem for C. albicans than for S. cerevisiae, which lacks significant levels of PUFAs
[33]. About 30% of the fatty acids in C. albicans are polyunsaturated [7, 8], which predisposes
them to forming lipid peroxides [9, 10]. These PUFAs are typically found in more complex lipids, such as phospholipids, in addition to existing as free fatty acids. Taken together, the results

PLOS Pathogens | DOI:10.1371/journal.ppat.1005147 September 1, 2015

13 / 24

New Antioxidant Mechanism for Fungal Pathogens

identify FLPs as an important new set of antioxidant enzymes in C. albicans. These results also
have broad significance for other pathogens, given that FLPs are induced by oxidative stress in
diverse fungi [11, 14, 48–50] and there is suggestive evidence that they play an antioxidant role
in bacteria [17, 19, 21, 27].

NAD(P)H quinone oxidoreductases are critical for resisting oxidative
stress
Biochemical studies of FLPs from bacteria, fungi, and plants have shown that they use NAD(P)
H to reduce quinones in a manner that avoids creation of hazardous semiquinone intermediates [23–27]. The Δ/Δ/Δ/Δ mutant was rescued by expression of E. coli wrbA (Fig 4), confirming that NAD(P)H quinone oxidoreductase activity plays an important antioxidant role in C.
albicans. Furthermore, heterologous expression of mammalian NQO1 in the Δ/Δ/Δ/Δ mutant
also rescued its sensitivity to oxidation and lipid peroxidation. Nqo1 does not share obvious
sequence similarity with FLPs even though it carries out a similar enzymatic activity. Although
there are some underlying structural similarities between Nqo1 and FLPs, they are quite distinct [19]. For example, Nqo1 binds FAD as a cofactor instead of FMN, and it forms dimers
rather than tetramers as seen for wrbA. These observations provide strong support that the key
function of the C. albicans FLPs is to act as quinone reductases.
Analysis of Δ/Δ/Δ/Δ cells engineered to express a single FLP gene indicated that they have
overlapping but distinct functions. Pst3 provided the best protection against the small molecule
quinones p-benzoquinone and menadione (Fig 5). In agreement with this, a pst3Δ mutant was
the only single FLP deletion mutant that was more sensitive to the small molecule quinones (pbenzoquinone and menadione) (Fig 5). In contrast, cells expressing only PST3 were less able to
resist other oxidants, such as linolenic acid or cumene hydroperoxide. These phenotypes are
consistent with different functional properties. However, it is also possible that some of these
differences are due to differential expression of the various FLP genes under the different conditions that were tested.

Ubiquinol is an important antioxidant in C. albicans
The most likely target for the quinone reductase activity of FLPs in C. albicans is ubiquinone
(coenzyme Q). Ubiquinone has a benzoquinone head group and a hydrophobic isoprenylated
tail that localizes it to membranes [32, 51]. Analogous to its well-known role as an electron carrier in the mitochondria, ubiquinone is present in other cellular membranes where its reduced
form (ubiquinol) can act as an antioxidant [30–34]. In particular, ubiquinol is thought to be
able to reduce lipid radicals that would otherwise propagate a chain reaction of lipid peroxidation to cause more extensive damage [9, 10]. To determine if ubiquinol plays an important
antioxidant role in C. albicans, COQ3 was deleted to block its synthesis. The coq3Δ mutant was
found to be very sensitive to oxidative stress and also displayed increased levels of lipid peroxidation in response to linolenic acid (Fig 6). In further support of the conclusion that FLPs act
on ubiquinone, rat NQO1, which is known to reduce ubiquinone [35, 36], can rescue the
defects of the Δ/Δ/Δ/Δ mutant (Figs 4 and 5).
There were interesting differences between the Δ/Δ/Δ/Δ mutant and the coq3Δ mutant that
reveal insights into their roles. Whereas the coq3Δ mutant was highly sensitive to oxidizing
conditions promoted by peroxides or PUFAs, it was not significantly altered in sensitivity to
p-benzoquinone and menadione (Fig 6). This indicates that the FLPs can reduce quinones in
the absence of ubiquinol. The coq3Δ mutant was also much more sensitive than the Δ/Δ/Δ/Δ
mutant to H2O2 and linolenic acid. One possibility is that other reductases can contribute
to reduction of ubiquinone in the absence of the FLPs. However, if these enzymes use a

PLOS Pathogens | DOI:10.1371/journal.ppat.1005147 September 1, 2015

14 / 24

New Antioxidant Mechanism for Fungal Pathogens

one-electron mechanism for reduction of quinones, they will generate deleterious semiquinone
radicals that would contribute to the phenotype of the Δ/Δ/Δ/Δ mutant.

FLPs are required for virulence and represent novel drug targets
The FLPs were required for virulence in a mouse model of hematogenously disseminated candidiasis (Fig 8A). Whereas the median survival time was 8 days for mice injected with 2.5 x 105
wild type C. albicans, all of the mice infected with the Δ/Δ/Δ/Δ mutant survived to the end of
the experiment (day 28). Thus, the Δ/Δ/Δ/Δ mutant appears to have a stronger virulence defect
than was reported for other C. albicans oxidation sensitive mutants including a cat1Δ catalase
mutant [52], a sod1Δ or sod5Δ superoxide dismutase mutant [53, 54], a grx2Δ glutathione
reductase mutant [53], or a tsa1Δ thioredoxin peroxidase mutant [55].
Interestingly, the Δ/Δ/Δ/Δ mutant could initially grow in the kidney essentially as well as a
wild type strain (Fig 8B). However, by day 4 there was about a 100-fold decrease in median
CFUs and 3 out of 9 mice cleared the infection. This decline in CFUs for the Δ/Δ/Δ/Δ mutant
correlates with the influx of neutrophils (Fig 8C) that typically peaks about day 2 of infection
[44, 45]. By day 28, all of the mice infected with the Δ/Δ/Δ/Δ mutant lacked detectable CFU
and appear to have cleared the infection. Generally similar results were reported for a C. albicans cat1Δ catalase mutant that also grew well initially, but then CFUs declined in most
infected mice [52]. In this regard it is also significant that a wrbAΔ mutant of the bacterial pathogen Yersinia tuberculosis can initiate an infection but is defective in establishing a persistent
infection [56].
This key role in virulence for the FLPs indicates they have strong potential to serve as novel
targets for antifungal therapy. New therapeutic approaches are needed; ~40% of patients with
systemic candidiasis succumb to the infection even with current antifungal therapy [57, 58].
This outcome is likely to worsen, as drug resistance is a growing problem for two of the three
most commonly used antifungal drugs [59, 60]. An important advantage of targeting FLPs is
that they do not have orthologs in humans. The analogous NAD(P)H quinone oxidoreductases
in mammals, Nqo1 and Nqo2, are very different [19].
Pharmacological studies on Nqo1 have identified multiple ways that quinone reductases
can be targeted. One approach is to identify inhibitors, such as dicoumarol that blocks the
Nqo1 activity [61]. In addition, the ability of Nqo1 to reduce small molecule quinones has been
studied as a basis for cancer chemotherapy. The fact that many cancer cells overexpress NQO1
has been exploited to develop novel therapies in which quinone compounds are reduced by
Nqo1 to convert them into a toxic form that preferentially kills cancer cells [36, 62]. Similarly,
Nqo1 has also been shown to reduce benzoquinone-containing ansamycin drugs, which makes
these compounds more potent inhibitors of the Hsp90 chaperone [63]. This suggests yet
another way drugs targeting FLPs could be useful, since Hsp90 inhibitors can prevent the
emergence of drug resistance in C. albicans [64]. Thus, the important roles of FLPs in oxidative
stress response and virulence, combined with their absence in mammalian cells, identifies
them as important new targets for therapeutic strategies aimed at combating fungal and bacterial pathogens.

Materials and Methods
Ethics statement
All procedures were approved by the Stony Brook University IACUC Committee (#1686).
Mice were considered to be moribund if food and water could no longer be accessed and then
humane euthanasia was performed by carbon dioxide inhalation as per instructions from the
Department of Laboratory Animals at Stony Brook University.
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Chemicals, strains and media
Oleic acid, linoleic acid, linolenic acid, α-tocopherol (vitamin E), hydrogen peroxide, tert-butyl
hydroperoxide, cumene hydroperoxide, menadione, p-benzoquinone, thiobarbituric acid
(TBA), hydrochloric acid, and 1,1,3,3-tetramethoxypropane were purchased from SigmaAldrich Corp. Trichloroacetic acid was from the Alfa Aesar Company, and nourseothricin
from Werner BioAgents.
The C. albicans strains used in this study are described in Table 1. Cells were grown in SD
medium (yeast nitrogen base synthetic medium with dextrose) [65]. C. albicans deletion mutants
were created in strain SN152 (arg4Δ his1Δ leu2Δ) by homologous recombination, as described
previously [66]. Mutant strains that carry homozygous deletion of PST1, PST2, PST3, YCP4, or
COQ3 were constructed with strain SN152 by the sequential deletion of both copies of the targeted gene. Gene deletion cassettes were generated by PCR amplification of the LEU2 or HIS1
selectable marker gene [66], using primers that also included ~80 bp of DNA sequence homologous to the upstream or downstream region of the targeted open reading frame (ORF). Cells that
had undergone homologous recombination to delete the targeted gene were identified by PCR
analysis. A pst3Δ ycp4Δ double mutant strain was constructed by simultaneous deletion of both
genes, taking advantage of the fact that they are adjacent in the genome. Homozygous triple and
quadruple deletion mutation strains were then constructed by sequential deletion of both copies
of the targeted gene using the SAT1 flipper method to recycle the selectable marker [37]. Similar
phenotypes were observed for independent isolates. Deletion strains were then made prototrophic by transforming with the ARG4 gene to correct the remaining auxotrophy.
Complemented strains, in which the wild-type FLP gene was reintroduced into the corresponding deletion mutant, were constructed by first using PCR to amplify the corresponding
FLP gene plus 2000 base pairs (bp) upstream and 501 bp downstream of the PST1 open reading
frame (ORF), 811 bp upstream and 427 bp downstream of the PST2 ORF, 1681 bp upstream
and 427 bp downstream of the PST3 ORF, or 1526 bp upstream and 310 bp downstream of the
YCP4 ORF. The DNA fragments were then inserted between the SacI and SacII sites in a derivative of plasmid pDDB57 [67] in which the URA3 gene was replaced with ARG4. The resulting
plasmids were then linearized by restriction digestion in the promoter region, and then transformed into the corresponding homozygous deletion mutant strains using ARG4 for selection.
The complementing plasmids were also transformed into the Δ/Δ/Δ/Δ mutant to create strains
that express only a single FLP gene. A fully complemented quadruple mutant strain was constructed essentially as described above, except that both PST1 and PST2 genes were cloned in
tandem into the ARG4 plasmid. The plasmid was digested with BspEI to linearize it in the promoter region of the PST1 gene, and then it was transformed into the quadruple mutant strain
LLF054. The PST3 and YCP4 genes were cloned between the SacI and ApaI restriction sites of a
derivative of plasmid pDDB57 in which the URA3 selectable marker was changed to the SAT1
gene to confer nourseothricin resistance. Note that the PST3 and YCP4 genes are adjacent in
the genome in a head to head manner, such that the corresponding open reading frames are
transcribed in a divergent manner. A PCR fragment that contains sequences between 1157 bp
downstream of the YCP4 ORF and 466 bp downstream of the PST3 ORF was used to create the
PST3-YCP4 complementing plasmid. The resulting plasmid was digested with SnaBI to linearize it about 400 bp downstream of the YCP4 open reading frame, and then the DNA was transformed into strain LLF078, a version of the Δ/Δ/Δ/Δ quadruple mutant in which the PST1 and
PST2 genes were already introduced as described above.
The open reading frames for E. coli wrbA and rat NQO1 were synthesized by GeneWiz
Corp. so that the codons could be optimized and to avoid CUG codons that are translated differently in C. albicans. The wrbA and NQO1 open reading frames were amplified by PCR and
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introduced downstream of the ADH1 promoter and GFP in plasmid pND391 that carries the
ARG4 selectable marker. The resulting plasmids were then transformed into the Δ/Δ/Δ/Δ
mutant strain LLF054 to create strains expressing wrbA (LLF074), NQO1 (LLF076), or GFP
(LLF080) as a control.

Growth assays to test sensitivity to oxidizing agents
Spot assays to test growth in the presence of oxidizing agents were carried out essentially as
described previously [68, 69]. C. albicans mutant or wild type strains were grown overnight
and then adjusted to 107 cells/ml. Serial 10-fold dilutions of cells were prepared, and three μl of
each dilution was then spotted onto solid agar SD medium containing the indicated chemical.
The plates were incubated at 37°C for 2 days and then photographed. Each assay was done at
least three independent times.
Cells were also tested in liquid culture for sensitivity to oxidizing agents by assaying colonyforming units (CFUs). C. albicans cells were grown in synthetic medium with 2% dextrose and
without amino acids at 37°C overnight. Cells were harvested at about 6–10 x 107 cells per ml,
washed once, and resuspended in phosphate buffer (0.1M sodium phosphate, pH 6.2, 0.2% dextrose) at 107 cells per ml. Three ml was transferred to a 15 ml glass test tube and then fatty acids
were added. Cells were then incubated at 37°C on a tube rotator for the designated period of time.
At the end of each treatment, cells were harvested by centrifugation and samples were plated to
determine the number of viable CFUs. Results represent the average of 3–6 independent assays.

Detection of thiobarbituric acid reactive substances (TBARS)
The level of TBARS in yeast whole cell lysates was determined by a modification of a previously
described procedure [70]. At the end of the fatty acid treatment described above, 1.5 x 107 cells
were harvested by centrifugation at 17,000 x g for 5 min, washed once with distilled water, and
resuspended in 100 μl distilled water in a screw cap tube. 1ml of a freshly prepared solution of
0.375% thiobarbituric acid dissolved in 12% trichloroacetic acid and 0.5 M hydrochloric acid was
added to each tube. After a 20-minute incubation at 90°C, samples were allowed to cool down,
and then the insoluble material was sedimented by centrifugation at 17,000 x g for 5 min. The
absorbance of the supernatant was measured at 535 nm, and corrected by subtracting the nonspecific absorbance at 600 nm. The corrected absorbance was then compared with a standard
curve created using 1,1,3,3-tetramethoxypropane treated under the same conditions, which generates malondialdehyde (MDA). Results represent the average of 3–4 independent experiments.

Microscopic analysis of GFP fusion proteins
The GFPγ variant was fused to the 3’ ends of the open reading frames for PST1 and PST3 using
HIS1 selection, in LLF018, as described previously [71]. Strains were verified by PCR analysis
and microscopic examination of GFP fluorescence. To add GFP at the 5’ end of the open reading frames to create N-terminal fusions, GFPγ was introduced downstream of the ADH1 promoter followed by the FLP gene and then the ADH1 terminator in pND397, which carries an
URA3 selectable marker gene [72]. The plasmids of pADH1-GFPγ-PST1, pADH1-GFPγPST2, or pADH1-GFPγ-PST3 were also linearized with Not I, before being individually transformed into LLF089 using URA3 as the selectable marker to create the strains LLF091, LLF092,
and LLF093. The plasmid pADH1-GFPγ-YCP4 was linearized with NotI and transformed into
LLF018 using URA3 as the selectable marker to construct the strain LLF071. GFP fluorescence
was analyzed directly in live cells without further processing using a Zeiss Axiovert 200M
microscope equipped with an AxioCam HRm camera and Zeiss AxioVision software for
deconvolving images.
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Table 1. Strains used.
C. albicans
strain

Parent

SN152

SC5314

arg4Δ/arg4Δ leu2Δ/leu2Δ his1Δ/his1Δ URA3/ura3Δ::imm IRO1/iro1Δ::
imm

LLF100

SN152

(prototrophic wild type control) arg4Δ/ARG4 leu2Δ/LEU2 his1Δ/HIS1
URA3/ura3Δ::imm IRO1/iro1Δ::imm

LLF052

SN152

(pst1Δ) pst1Δ::HIS1/pst1Δ::LEU2 ARG4/arg4Δ

LLF059

SN152

(pst2Δ) pst2Δ::HIS1/pst2Δ::LEU2 ARG4/arg4Δ

LLF036

SN pst3Δ

(pst3Δ) pst3Δ::HIS1/pst3Δ::LEU2 ARG4/arg4Δ

LLF037

SN ycp4Δ

(ycp4Δ) ycp4Δ::HIS1/ycp4Δ::LEU2 ARG4/arg4Δ

LLF025

SN152

(pst3Δ ycp4Δ) pst3-ycp4Δ::HIS1/pst3-ycp4Δ::LEU2 arg4Δ/arg4Δ

LLF034

LLF025

(pst3Δ ycp4Δ) pst3-ycp4Δ::HIS1/pst3-ycp4Δ::LEU2 ARG4/arg4Δ

LLF032

LLF025

(pst2Δ pst3Δ ycp4Δ) pst3-ycp4Δ::HIS1/pst3-ycp4Δ::LEU2 pst2Δ::frt/
pst2Δ::frt arg4Δ/arg4Δ

LLF063

LLF032

(pst2Δ pst3Δ ycp4Δ) pst3-ycp4Δ::HIS1/pst3-ycp4Δ::LEU2 pst2Δ::frt/
pst2Δ::frt ARG4/arg4Δ

LLF054

LLF032

(Δ/Δ/Δ/Δ) pst3-ycp4Δ::HIS1/pst3-ycp4Δ::LEU2 pst2Δ::frt/pst2Δ::frt
pst1Δ::frt/pst1Δ::frt arg4Δ/arg4Δ

LLF060

LLF054

(Δ/Δ/Δ/Δ) LLF054 except for ARG4/arg4Δ

LLF079

LLF054

(Compl.) pst3-ycp4Δ::HIS1/pst3-ycp4Δ::LEU2 pst2Δ::frt/pst2Δ::frt
pst1Δ::frt/pst1Δ::frt PST2-PST1::ARG4 arg4Δ/arg4Δ PST3-YCP4::SAT1

LLF074

LLF054

(+wrbA) pst3-ycp4Δ::HIS1/pst3-ycp4Δ::LEU2 pst2Δ::frt/pst2Δ::frt
pst1Δ::frt/pst1Δ::frt pADH1-GFPγ-EcWrbA::ARG4 arg4Δ/arg4Δ

LLF076

LLF054

(+NQO1) pst3-ycp4Δ::HIS1/pst3-ycp4Δ::LEU2 pst2Δ::frt/pst2Δ::frt
pst1Δ::frt/pst1Δ::frt pADH1-GFPγ-rat NQO1::ARG4 arg4Δ/arg4Δ

LLF080

LLF054

(+GFP) pst3-ycp4Δ::HIS1/pst3-ycp4Δ::LEU2 pst2Δ::frt/pst2Δ::frt
pst1Δ::frt/pst1Δ::frt pADH1-GFPγ::ARG4 arg4Δ/arg4Δ

LLF064

LLF054

(+PST1) pst3-ycp4Δ::HIS1/pst3-ycp4Δ::LEU2 pst2Δ::frt/pst2Δ::frt
pst1Δ::frt/pst1Δ::frt PST1::ARG4 arg4Δ/arg4Δ

LLF081

LLF054

(+PST2) pst3-ycp4Δ::HIS1/pst3-ycp4Δ::LEU2 pst2Δ::frt/pst2Δ::frt
pst1Δ::frt/pst1Δ::frt PST2::ARG4 arg4Δ/arg4Δ

LLF066

LLF054

(+PST3) pst3-ycp4Δ::HIS1/pst3-ycp4Δ::LEU2 pst2Δ::frt/pst2Δ::frt
pst1Δ::frt/pst1Δ::frt PST3::ARG4 arg4Δ/arg4Δ

LLF082

LLF054

(+YCP4) pst3-ycp4Δ::HIS1/pst3-ycp4Δ::LEU2 pst2Δ::frt/pst2Δ::frt
pst1Δ::frt/pst1Δ::frt YCP4::ARG4 arg4Δ/arg4Δ

LLF083

SN
orf19.2570Δ

orf19.2570Δ::HIS1/ orf 19.2570Δ::LEU2 ARG4/arg4Δ

LLF084

SN
orf19.6607Δ

orf19.6607Δ::HIS1/ orf 19.6607Δ::LEU2 ARG4/arg4Δ

LLF088

SN152

(coq3Δ) coq3Δ::HIS1/coq3Δ::LEU2 ARG4/arg4Δ

BWP17

SC5314

ura3Δ::λimm434/ura3 Δ::λ imm434 his1::hisG/his1::hisG arg4::hisG/
arg4::hisG

LLF018

BWP17

LSP1/LSP1-mCherry::ARG4 ura3Δ::λimm434/ura3 Δ::λ imm434 his1::
hisG/his1::hisG arg4::hisG/arg4::hisG

LLF098

LLF018

PST1/PST1-GFPγ::HIS1 LSP1/LSP1-mCherry::ARG4 ura3Δ::λimm434/
ura3 Δ::λ imm434 his1::hisG/his1::hisG arg4::hisG/arg4::hisG

LLF090

LLF018

PST3/PST3-GFPγ::HIS1 LSP1/LSP1-mCherry::ARG4 ura3Δ::λimm434/
ura3 Δ::λ imm434 his1::hisG/his1::hisG arg4::hisG/arg4::hisG

LLF071

LLF018

pADH1-GFPγ-YCP4::URA3 LSP1/LSP1-mCherry::ARG4 ura3Δ::
λimm434/ura3 Δ::λ imm434 his1::hisG/his1::hisG arg4::hisG/arg4::hisG

LLF089

BWP17

pADH1-mCherry-YCP4::SAT1 ura3Δ::λimm434/ura3 Δ::λ imm434 his1::
hisG/his1::hisG arg4::hisG/arg4::hisG

LLF092

LLF089

pADH1-GFPγ-PST2::URA3 pADH1-mCherry-YCP4::SAT1 ura3Δ::
λimm434/ura3 Δ::λ imm434 his1::hisG/his1::hisG arg4::hisG/arg4::hisG

Genotype

doi:10.1371/journal.ppat.1005147.t001
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Mouse virulence assays
The survival of C. albicans cells in the presence of macrophages was assayed essentially as
described previously [73]. Bone marrow was isolated from femurs of 6- to 8-week-old female
C57BL/6 mice (Jackson Laboratories) and then macrophages were derived from them as
previously described [74]. At 18 h prior to infection, bone marrow derived macrophages were
seeded into multiwell trays in Dulbecco’s modified Eagle medium (Invitrogen) supplemented with
10% fetal bovine serum (HyClone), 15% L-cell-conditioned medium, 1 mM sodium pyruvate, 2
mM glutamate, and 100 ng/ml E. coli LPS (Sigma). Dilutions of C. albicans cells were then plated
in multiwell trays in the presence or absence of the macrophages and incubated for 48 h [73].
Microcolonies of growth in each well were then counted to determine the reduction in C. albicans
viability due to the presence of macrophages. The results represent the average of three different
experiments in which different batches of bone marrow-derived macrophages were used.
C. albicans strains were tested for virulence in a mouse model of hematogenously disseminated candidiasis similar to previous studies [45, 75]. C. albicans cells were cultured by growing
overnight at 30°C in YPD medium with 80 μg/ml uridine, reinoculating into fresh medium,
and incubating again overnight at 30°C. Cells were prepared for infection assays by washing
twice in phosphate-buffered saline (PBS), counting in a hemocytometer, and then diluting to
1.25 x 106 cells/ml with PBS. Female BALB/c mice were injected via the lateral tail vein with 2.5
x 105 cells, and then monitored at least twice a day for 28 days. Statistical analyses of the results
for the survival studies were carried out using a log rank test (Mantel-Haenszel) with the Prism
6 software program (GraphPad Software, Inc., La Jolla, CA). To assess fungal burden, kidneys
were excised, weighed, and then homogenized in 5 ml PBS for 30 s with a tissue homogenizer
(Pro Scientific Inc.). The CFU per gram of kidney was determined by plating dilutions of the
homogenates on YPD agar medium plates, and incubating for 2 days at 30°C. Statistical analysis of the CFU data was carried out with Prism 6 software using one-way analysis of variance
with a nonparametric Kruskal-Wallis test and Dunn’s post-hoc test. For histological analysis,
kidneys were excised from mice 2 d post infection, fixed with formaldehyde, and then stained
with Hematoxylin and Eosin (H&E) to detect leukocytes or with Gomori-Methenamine Silver
(GMS) to detect fungal cells by McClain Laboratories, Smithtown, NY.

Accession numbers
The accession numbers for the C. albicans genes used in this study are as follows:
Standard Name

Systematic Name

Orf19 Name

GenBank Designation

PST1

C2 06870C

orf19:2241

XP 714771:1

PST2

C2 08640C

orf19:3612

XP 714456:1

PST3

CR 05390W

orf19:5285

XP 710366:1

YCP4

CR 05380C

orf19:5286

XP 710367:1

COQ3

C6 01840C

orf19:3400

XP 716710:1

Supporting Information
S1 Fig. Amino acid alignment of C. albicans FLPs and E. coli WrbA. The amino acid
sequences were aligned using the Clustal W program. Key regions in the WrbA protein are
highlighted, as determined by analysis of the high-resolution crystal structure of E. coli WrbA
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[19, 22]. Note that there is a high degree of amino acid similarity in the critical functional sites.
(TIF)
S2 Fig. The Δ/Δ/Δ/Δ mutant strain is not more sensitive to oleic acid. C. albicans strains
were incubated with 0.5 mM oleic acid (OA) at 37°C for the indicated time (hours), and then
dilutions of cells were plated to determine the viable colony forming units (CFU). These studies
assays were carried out as controls for the cells incubated in the presence of linolenic acid
(LNA) shown in Fig 2A. Strains used included the wild type strain LLF100, Δ/Δ/Δ/Δ strain
LLF060, and the complemented strain LLF079 in which one copy of each FLP gene was introduced into the Δ/Δ/Δ/Δ strain.
(TIF)
S3 Fig. Western blot analysis of GFP fusion proteins. C. albicans cells containing fusions
between GFP and the indicated FLP gene were analyzed on a Western blot probed with a
mouse monoclonal anti-GFP antibody. The protein bands were detected using a secondary
IRDye 800CW conjugated Goat (polyclonal) anti-mouse IgG antibody, and an image was
acquired using a digital Odyssey infrared imaging system. To gain increased sensitivity, samples on the left side were expressed using a MET3 promoter and an ADH1 promoter was used
for the samples on the right side, as indicated at the bottom. The position of pre-stained molecular weight markers (kD) is shown on the left side. The expected position for GFP is indicated
on the right. Also on the right side, Pst indicates the approximate position for a GFP fusion to
the Pst1, Pst2 or Pst3 proteins, and Ycp4 indicates the position for GFP-Ycp4. Note that Ycp4
is about 8 kD larger than the Pst1, Pst2, and Pst3 proteins and displays the expected difference
in gel mobility on the blot.
(TIF)
S4 Fig. Macrophage killing of C. albicans strains. C. albicans strains were plated in multiwell
trays in the absence or presence of macrophages derived from mouse bone marrow cells.
Microcolonies of growth in each well were then counted to determine the reduction in C. albicans viability due to the presence of macrophages [73]. The results represent the average of
three independent experiments. There was no significant difference in killing of the different C.
albicans strains, as determined by ANOVA. Error bars indicate SD.
(TIF)
S5 Fig. Mouse virulence assays for the double mutant (pst3Δ ycp4Δ) and triple mutant
(pst2Δ pst3Δ ycp4Δ). The double (pst3Δ ycp4Δ) and triple (pst2Δ pst3Δ ycp4Δ) FLP mutant C.
albicans strains were assayed for virulence in a mouse model of systemic Candidiasis as
described in Fig 8. Although mice infected with the triple mutant appeared to show slightly better survival, it was not statistically significant as judged by a log rank test (Mantel-Haenszel).
Wild type control strain LLF100 was used to infect 14 mice, pst3Δ ycp4Δ strain LLF034 was
used to infect 7 mice, and pst2Δ pst3Δ ycp4Δ strain LLF063 was used to infect 8 mice.
(TIF)
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